Baltimore , Maryland
PhD, Johns Hopkins University
My research area is the design and coordination of multicenter clinical trials and longitudinal observational studies. I also am interested in the use of quality of life outcomes in trials.
Disease areas of interest are: Alzheimer's disease and other neurological and mental health conditions in older people; and AIDS and its complications, particularly CMV retinitis.
Honors and Awards
Clinical Trials Training Grant recipient, 1993-1996
National Merit Scholar
quality of life
- Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AKG, Meinert CL, Reshef DS for the Studies of Ocular Complications of AIDS Research Group. Risk factors for advancement of cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 118:1196-1204, 2000.
Martin BK, Gilpin AMK, Jabs DA, Wu AW for the Studies of Ocular Complications of AIDS Research Group. Reliability, validity, and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis. J Clin Epidemiol 54:376-386, 2001.
Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F, for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infect Dis 183:333-337, 2001.
Carlson MC, Tschanz JT, Norton MC, Welsh-Bohmer K, Martin BK, Greene J, Breitner JCS. H2 Histamine Receptor Blockade in the Treatment of Alzheimer’s Disease: A randomized, double-blind, placebo-controlled trial of nizatidine. Alzheimer Dis Assoc Disord 16:24-30, 2002.
Jabs DA, Martin BK, Forman MS, Dunn JP, Davis JL, Weinberg DV, Biron KK, Baldanti F for the Cytomegalovirus Retinitis and Viral Resistance Study Group. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Am J Ophthalmol 132:700-710, 2002.